Cell adhesion suppresses autophagy via Src/FAK-mediated phosphorylation and inhibition of AMPK

Ming Zhao1, Darren Finlay1, Elizabeth Kwong1

  • 1Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Cellular Signalling
|October 21, 2021
PubMed

Insights

Cell adhesion signaling via Src suppresses autophagy by phosphorylating AMPK. This discovery reveals a new regulatory pathway impacting cell homeostasis and cancer progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Autophagy is a crucial cellular process regulated by AMP-activated protein kinase (AMPK).
  • AMPK activation, particularly through T172 phosphorylation, is vital for its signaling.
  • Integrin-mediated cell adhesion activates the Src/Focal Adhesion Kinase (FAK) pathway, influencing cell survival.

Purpose of the Study:

  • To investigate the interplay between Src signaling and AMPK-mediated autophagy.
  • To identify novel regulatory mechanisms of autophagy in response to cell adhesion.
  • To explore the therapeutic potential of targeting this pathway in cancer.

Main Methods:

  • Utilized chemical inhibitors and genetic cell models.
  • Employed targeted mutagenesis to study specific phosphorylation sites.
  • Investigated autophagy induction under various stimuli, including glucose starvation.

Main Results:

  • Src signaling phosphorylates the AMPK-α subunit at a novel site (tyrosine 179).
  • This phosphorylation suppresses AMPK-T172 phosphorylation and inhibits autophagy during cell adhesion.
  • Src and FAK were confirmed to suppress AMPK signaling and autophagy induced by glucose starvation.
  • Combined treatment with hydroxychloroquine and Src inhibitors promoted apoptosis in cancer cells.

Conclusions:

  • Src/FAK signaling directly inhibits AMPK and autophagy via novel tyrosine phosphorylation.
  • This pathway is a key regulator of cellular homeostasis and is implicated in tumor progression.
  • Targeting the Src/FAK-AMPK-autophagy axis presents a potential therapeutic strategy for cancer.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.9K